Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.

Moreno C, Prieto P, Macías Á, Pimentel-Santillana M, de la Cruz A, Través PG, Boscá L, Valenzuela C.

J Immunol. 2013 Dec 15;191(12):6136-46. doi: 10.4049/jimmunol.1300235. Epub 2013 Nov 18.

2.

Pattern of Kv beta subunit expression in macrophages depends upon proliferation and the mode of activation.

Vicente R, Escalada A, Soler C, Grande M, Celada A, Tamkun MM, Solsona C, Felipe A.

J Immunol. 2005 Apr 15;174(8):4736-44.

3.

Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages.

Vicente R, Escalada A, Coma M, Fuster G, Sánchez-Tilló E, López-Iglesias C, Soler C, Solsona C, Celada A, Felipe A.

J Biol Chem. 2003 Nov 21;278(47):46307-20. Epub 2003 Aug 15. Erratum in: J Biol Chem. 2005 Apr 1;280(13):13204.

4.

Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells.

Wang YP, Wu Y, Li LY, Zheng J, Liu RG, Zhou JP, Yuan SY, Shang Y, Yao SL.

J Neuroinflammation. 2011 Aug 10;8:95. doi: 10.1186/1742-2094-8-95.

5.
6.

Characterisation of K+ currents in the C8-B4 microglial cell line and their regulation by microglia activating stimuli.

Moussaud S, Lamodière E, Savage C, Draheim HJ.

Cell Physiol Biochem. 2009;24(3-4):141-52. doi: 10.1159/000233240. Epub 2009 Aug 3.

7.

Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.

Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M.

J Pharmacol Exp Ther. 2010 Feb;332(2):541-8. doi: 10.1124/jpet.109.159046. Epub 2009 Oct 21.

8.

Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.

Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF.

Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):89-98. Epub 2006 Nov 7.

PMID:
17259075
10.

Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.

Villalonga N, David M, Bielanska J, Vicente R, Comes N, Valenzuela C, Felipe A.

J Gen Physiol. 2010 Feb;135(2):135-47. doi: 10.1085/jgp.200910334.

12.

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.

Hashimoto A, Hayashi I, Murakami Y, Sato Y, Kitasato H, Matsushita R, Iizuka N, Urabe K, Itoman M, Hirohata S, Endo H.

J Rheumatol. 2007 Nov;34(11):2144-53. Epub 2007 Oct 1.

PMID:
17918787
14.

Ion channel expression in PMA-differentiated human THP-1 macrophages.

DeCoursey TE, Kim SY, Silver MR, Quandt FN.

J Membr Biol. 1996 Jul;152(2):141-57.

PMID:
9139125
15.
16.

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

Huang YH, Wang HM, Cai ZY, Xu FY, Zhou XY.

Inflammation. 2014 Aug;37(4):1084-90. doi: 10.1007/s10753-014-9832-2.

PMID:
24522831
17.

Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells.

Attali B, Wang N, Kolot A, Sobko A, Cherepanov V, Soliven B.

J Neurosci. 1997 Nov 1;17(21):8234-45.

18.

Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.

Sato Y, Kitasato H, Murakami Y, Hashimoto A, Endo H, Kondo H, Inoue M, Hayashi I.

Biomed Pharmacother. 2004 Jul-Aug;58(6-7):381-7.

PMID:
15271420
19.

Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.

Hu F, Liu XX, Wang X, Alashkar M, Zhang S, Xu JT, Zhong XL, He MW, Feng AP, Chen HX.

J Dermatol Sci. 2015 Jun;78(3):181-8. doi: 10.1016/j.jdermsci.2015.03.009. Epub 2015 Mar 21.

PMID:
25847211
20.

Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.

Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel AM, Gola M, Sabatier JM, Bernard D, Crest M, Béraud E.

J Immunol. 2001 Jan 15;166(2):936-44.

Supplemental Content

Support Center